HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masayoshi Abe Selected Research

Gluconates (Copper Gluconate)

8/2008Carcinogenic risk of copper gluconate evaluated by a rat medium-term liver carcinogenicity bioassay protocol.
5/2008Possible carcinogenic risks of copper gluconate and their prevention by co-administered green tea catechins evaluated by a rat medium-term multi-organ carcinogenicity bioassay protocol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masayoshi Abe Research Topics

Disease

6Inflammation (Inflammations)
08/2008 - 12/2004
6Asthma (Bronchial Asthma)
04/2007 - 12/2004
3Anaphylaxis (Anaphylactic Shock)
12/2007 - 01/2005
2Neoplasms (Cancer)
07/2014 - 08/2008
2Cleft Palate (Palate, Cleft)
11/2004 - 04/2004
1Bradycardia
07/2018
1Bundle-Branch Block (Fascicular Block)
07/2018
1Adenoma (Adenomas)
03/2012
1Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2011
1Carcinogenesis
04/2009
1Hypertrophy
11/2008
1Hyperplasia
05/2008
1Necrosis
10/2007
1Rheumatoid Arthritis
07/2006
1Reperfusion Injury
07/2006
1Psoriasis (Pustulosis Palmaris et Plantaris)
07/2006
1Hepatocellular Carcinoma (Hepatoma)
07/2005
1Rhinitis
12/2004
1Prostatic Neoplasms (Prostate Cancer)
12/2004
1Atherosclerosis
12/2004
1Leukemia
07/2003

Drug/Important Bio-Agent (IBA)

3Complement System Proteins (Complement)IBA
04/2007 - 01/2005
2Gluconates (Copper Gluconate)IBA
08/2008 - 05/2008
2Messenger RNA (mRNA)IBA
08/2008 - 12/2007
2acetylated peptide AIBA
04/2007 - 01/2005
2Pharmaceutical PreparationsIBA
04/2007 - 12/2004
2AnaphylatoxinsIBA
07/2006 - 01/2005
2cysteinyl-leukotrieneIBA
02/2005 - 12/2004
2MethylprednisoloneFDA LinkGeneric
02/2005 - 07/2003
2LeukotrienesIBA
01/2005 - 12/2004
1Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA
07/2018
1Keratins (Keratin)IBA
07/2014
1AmylasesFDA Link
07/2014
1Insulin (Novolin)FDA Link
07/2014
1CarcinogensIBA
07/2014
1Phenobarbital (Luminal)FDA Link
03/2012
1Colloids (Colloid)IBA
03/2012
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2011
1Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
01/2011
18-hydroxyguanineIBA
04/2009
1AntioxidantsIBA
04/2009
1EnzymesIBA
04/2009
1DNA Glycosylases (DNA Glycosylase)IBA
04/2009
1Ketoconazole (Nizoral)FDA LinkGeneric
11/2008
1MetalsIBA
08/2008
1CalciumIBA
10/2007
1N- ((4- dimethylaminophenyl)methyl)- N- (4- isopropylphenyl)- 7- methoxy- 1,2,3,4- tetrahydronaphthalen- 1- carboxamideIBA
04/2007
1Monoclonal AntibodiesIBA
07/2006
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
03/2006
1Choline (Choline Chloride)IBA
07/2005
1Amino AcidsFDA Link
07/2005
1montelukast (Singulair)FDA Link
02/2005
1leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA
02/2005
1SteroidsIBA
02/2005
1Peptides (Polypeptides)IBA
01/2005
1Anaphylatoxin C5a ReceptorIBA
01/2005
1Phospholipids (Phosphatides)FDA LinkGeneric
12/2004
1Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA
12/2004
1Lipoxygenase (Lipoxygenase-1)IBA
12/2004
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
12/2004
1Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
12/2004
1Lipoxygenase InhibitorsIBA
12/2004
1Indoleacetic Acids (Auxin)IBA
11/2004
1indoleacetic acid (indole acetic acid)IBA
11/2004
1GlucocorticoidsIBA
04/2004
1TAC AlternateIBA
04/2004
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
04/2004
1Leukotriene C4IBA
07/2003
1Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2003
1Dactinomycin (Actinomycin)FDA LinkGeneric
07/2003

Therapy/Procedure

1Therapeutics
02/2005